|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2011-3-18
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Prior pilot studies support the use of antiviral medications with topical corticosteroids for herpes simplex labialis (HSL). ME-609 (Xerese, Xerclear) is a combination of 5% acyclovir and 1% hydrocortisone developed for the topical treatment of HSL.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1097-6787
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
64
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
696.e1-11
|
|
pubmed:meshHeading |
pubmed-meshheading:20851499-Acyclovir,
pubmed-meshheading:20851499-Adult,
pubmed-meshheading:20851499-Antiviral Agents,
pubmed-meshheading:20851499-Double-Blind Method,
pubmed-meshheading:20851499-Drug Combinations,
pubmed-meshheading:20851499-Female,
pubmed-meshheading:20851499-Herpes Labialis,
pubmed-meshheading:20851499-Humans,
pubmed-meshheading:20851499-Hydrocortisone,
pubmed-meshheading:20851499-Male,
pubmed-meshheading:20851499-Middle Aged,
pubmed-meshheading:20851499-Placebos,
pubmed-meshheading:20851499-Recurrence,
pubmed-meshheading:20851499-Self Administration,
pubmed-meshheading:20851499-Severity of Illness Index,
pubmed-meshheading:20851499-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Early treatment of cold sores with topical ME-609 decreases the frequency of ulcerative lesions: a randomized, double-blind, placebo-controlled, patient-initiated clinical trial.
|
|
pubmed:affiliation |
Department of Dermatology, School of Medicine, University of Utah, Salt Lake City, Utah 84132-2409, USA. Christopher.Hull@hsc.utah.edu
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
